Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

ACHIEVE LIFE SCIENCES, INC.
Next earnings Aug 5, 2026 · consensus $-0.16 EPS
Last earnings +7.2% on 2026-05-12
Conservative balance sheet (liabilities/equity 0.94x).
ACHIEVE LIFE SCIENCES, INC. shows $0.00 in FY2019 revenue, and -254.0% ROE.
Sources: SEC EDGAR (CIK 0000949858, latest 10-Q filed 2026-05-12) · EODHD · as of 6/22/2026, 12:31:39 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| Diluted EPS | -$4.08 | -$4.00 | -$1.50 | -$1.24 | -$1.25 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.